Mynvax is an India-based biotech startup that develops next-generation ‘Warm’ vaccines for covid and influenza. Additionally, the technology allows for very rapid, large-scale, and low-cost production of vaccines that could potentially be used to protect people in case of a pandemic. Founded in 2017 Mynvax, was incubated at the Indian Institute of Science, Bangalore. GoodWorks Angel Fund co-invested in this path-breaking startup with LetsVenture.”

For more information, check out this video –